Direct oral anticoagulants (DOACs)
نویسندگان
چکیده
منابع مشابه
Perioperative Management of Direct Oral Anticoagulants (DOACs): A Systemic Review
Direct oral anticoagulants (DOACs) are in wide use among patients requiring both short- and long-term anticoagulation, mainly due to their ease of use and the lack of monitoring requirements. With growing use of DOACs, it is imperative that physicians be able to manage patients on these medications, especially in the perioperative period. We aim to provide guidance on the management of DOACs in...
متن کاملDirect oral anticoagulants (DOACs) and pregnancy: A plea for better information.
The use of anticoagulants in pregnant women is problematic. Many anticoagulants cross the placenta and have the potential to be fetopathic as well as to anticoagulate the fetus. In the early 1980s, a paper by Hall et al. (1) suggested that adverse pregnancy outcomes, such as warfarin embryopathy, an increased risk of miscarriages, anticoagulation of the fetus, and possibly other abnormalities w...
متن کاملReversal of direct oral anticoagulants
Reversal agents for direct oral anticoagulants (DOACs), including factor X inhibitors and direct thrombin inhibitors, are a major concern in clinical practice. After DOACs were introduced and became widely used as an alternative for vitamin K antagonists in the management of venous thromboembolism and nonvalvular atrial fibrillation, the need for effective reversal agents has increased, particu...
متن کاملDirect Oral Anticoagulants for Acute Venous Thromboembolism: Closing the Circle? Running title: Verhamme et al.; DOACs for acute venous thromboembolism
Ad Ad Addr dr dres es ess s s fo fo for r r Co Co Corr rr rres es espo po pond nd nden en ence ce ce: : :
متن کاملDirect oral anticoagulants and venous thromboembolism.
Venous thromboembolism (VTE), consisting of deep vein thrombosis and pulmonary embolism, is a major clinical concern associated with significant morbidity and mortality. The cornerstone of management of VTE is anticoagulation, and traditional anticoagulants include parenteral heparins and oral vitamin K antagonists. Recently, new oral anticoagulant drugs have been developed and licensed, includ...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Vascular Medicine
سال: 2015
ISSN: 1358-863X,1477-0377
DOI: 10.1177/1358863x15600256